Titlebook: Gallbladder Cancer; Current Treatment Op Vijay Kumar Shukla,Manoj Pandey,Ruhi Dixit Book 2023 The Editor(s) (if applicable) and The Author(

NUDGE

Graphite

Book 2023atment therapeutics targets for gallbladder cancer patients have been identified and the field is evolving rapidly. . The book is relevant for the clinical researcher, surgeon, scientist and academician..

Commonplace

黃瓜

粗鄙的人

GROVE

健忘癥

The Analysis of Business ProcessesERK, PI3K/AKT/mTOR, ErbB1, TP53, HER2, KRAS, VEGF, HIF1, and PTCH1/SMO/GLI1 in gallbladder cancer pathogenesis. Developing an effective targeted therapy by inhibiting these signaling molecules has potential to elevate the treatment efficacy of gallbladder cancer.

ETCH

Gallbladder Cancer: Current Treatment Options and Therapeuticsches (such as miRNA/siRNA) which may enhance sensitivity of tumor cells to chemotherapeutic drugs. In addition, noncoding RNAs including miRNAs and lncRNAs have been considered as novel therapeutic measures in controlling progression of gallbladder carcinoma.

Externalize

A Look at Emerging Therapeutic Targets for Gallbladder Cancer: A Multi-Omics Approachns are dysregulated in GBC. Importantly, we highlight their potential use as therapeutic biomarkers due to their functions in GBC progression. Lastly, we review emerging strategies such as immunotherapy and their potential of improving patient survival.

使人入神

Targeted Treatment of Gallbladder Cancera is an early sign of potential of targeted therapy in biliary tract cancers which is enriched in targetable molecular pathways in two-third of the cases. We reviewed the literature and highlighted the emerging new and effective treatment strategies for this otherwise aggressive and fatal disease.